← All organizations

Princess Maxima Center for Pediatric Oncology

Academic/Hospital

Also known as: Princess Maxima Center for Pediatric Oncology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 1, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (29 distinct, 13 trials)

Phase 4 (1 own, 0 via acquisition)

vincristine

Phase 3 (8 own, 0 via acquisition)

Phase 2 (16 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Recent trials (17)

NCT07175415Lead sponsorPhase 1/Phase 2Oct 1, 2026
NCT07223021CollaboratorPhase 3Oct 20, 2025
NCT06485947Lead sponsorPhase 1Jul 1, 2024
NCT06485947OfficialPhase 1Jul 1, 2024
NCT06262438Lead sponsorPhase 2Feb 6, 2024
NCT05751044Lead sponsorPhase 1/Phase 2Oct 1, 2023
NCT05740449Lead sponsorPhase 1/Phase 2Oct 1, 2023
NCT05740449Study chairPhase 1/Phase 2Oct 1, 2023
NCT05745714Lead sponsorPhase 1/Phase 2Oct 1, 2023
NCT05740449OfficialPhase 1/Phase 2Oct 1, 2023
NCT05844670CollaboratorPhase 4Apr 20, 2023
NCT05658640Lead sponsorPhase 1/Phase 2Apr 1, 2023
NCT05183035OfficialPhase 3Oct 1, 2022
NCT05183035Study directorPhase 3Oct 1, 2022
NCT05327894Lead sponsorPhase 3Sep 30, 2022

Details

Last known activity: Oct 1, 2026